Patents by Inventor Osamu Matsushita

Osamu Matsushita has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190363932
    Abstract: A data collecting apparatus (10) is connected to a device (20) via a network (31, 32), and includes a collector (142, 142), a communication controller (130), and a process execution controller (110). The collector (141, 142) collects data from the device (20) based on collection setting information, converts format of the data collected, and outputs the data whose format is converted. The communication controller (130) manages an addition of the collector (141, 142), provides the collection setting information to the collector (141, 142), and outputs data collected by the collector (141, 142). The process execution controller (110) manages processing of data outputted from the communication controller (130). The collector (141, 142) is provided as plug-in software (121, 122) containing information regarding a parameter setting item for when data is collected. The collection setting information is information in which a setting value is added with respect to the parameter setting item.
    Type: Application
    Filed: November 6, 2017
    Publication date: November 28, 2019
    Applicant: Mitsubishi Electric Corporation
    Inventors: Osamu NASU, Yusuke MATSUSHITA
  • Publication number: 20190338010
    Abstract: Fusion proteins containing active agonist or antagonist fragments of parathyroid hormone (PTH) and parathyroid hormone related peptide (PTHrP) coupled to a collagen-binding domain are presented. The fusion proteins can be used to promote bone growth, to promote hair growth, to prevent cancer metastasis to bone, to promote immune reconstitution with a bone marrow stem cell transplant, to promote mobilization of bone marrow stem cells for collection for autologous stem cell transplant, and to treat renal osteodystrophy. Pharmaceutical agents comprising a collagen-binding polypeptide segment linked to a non-peptidyl PTH/PTHrP receptor agonist or antagonist are also presented.
    Type: Application
    Filed: July 22, 2019
    Publication date: November 7, 2019
    Applicants: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS, OCHSNER CLINIC FOUNDATION, NATIONAL UNIVERSITY CORPORATION KAGAWA UNIVERSITY
    Inventors: Robert C. Gensure, Joshua Sakon, Osamu Matsushita, Tulasi Ponnapakkam
  • Patent number: 10401414
    Abstract: A method of testing a receptor of a wind turbine includes a step of moving an unmanned aerial vehicle (UAV) close to the receptor of a wind turbine blade mounted to a hub of the wind turbine, and performing an electric continuity test on the receptor.
    Type: Grant
    Filed: February 8, 2017
    Date of Patent: September 3, 2019
    Assignee: MITSUBISHI HEAVY INDUSTRIES, LTD.
    Inventors: Takatoshi Matsushita, Keisuke Ota, Osamu Hasegawa, Kengo Imaoka, Koji Fukami
  • Publication number: 20190259984
    Abstract: A battery pack houses first and second cell units that are composed of a plurality of cells, and has a positive electrode power source terminal and a negative electrode power source terminal. This battery pack is provided with a series connector capable of connecting, in series, the first and second cell units and a parallel connector capable of connecting, in parallel, the first and second cell units, and is capable of switching between a parallel connection voltage and a series connection voltage. In the case of attachment to the high voltage electrical device body, the series connector becomes conductive and the parallel connector pair is cut off by the action of the series/parallel switching terminal. In the case of attachment to a low voltage electrical device body, the state is returned to an initial state, the series connector is cut off, and the parallel connector pair becomes conductive.
    Type: Application
    Filed: October 27, 2017
    Publication date: August 22, 2019
    Applicant: Koki Holdings Co., Ltd.
    Inventors: Tomomasa NISHIKAWA, Takuya Teranishi, Naoto Wakatabe, Akira Matsushita, Masaru Hirano, Osamu Kawanobe, Nobuhiro TAKANO, Shinji Watanabe, Hiroyuki HANAWA, Takuhiro Murakami, SHOTA KANNO, Junpei Sato, Hikaru Tamura, Hayato Yamaguchi, Toshio Mizoguchi, Yasushi Nakano, Kazuhiko FUNABASHI, Masayuki Ogura, Yusuke FUNABIKI, Junichi Toukairin, Shota Takeuchi
  • Publication number: 20190260209
    Abstract: In order that the output voltage of a battery pack can be switched and the battery pack can be shared among different voltage electric appliances, this battery pack has a switching mechanism that switches outputting a low voltage by parallel connection of two cell units or outputting a high voltage by series connection of the two cell units, said two cell units each being composed of a plurality of cells connected in series, wherein the switching mechanism is configured from a change-over switch having an operation lever (452). The change-over switch is embedded in a battery pack (400), and an operator is able to manually switch outputting 18 V by setting the operation lever (452) at a first position or outputting 36 V by setting the operation lever (452) at a second position.
    Type: Application
    Filed: October 27, 2017
    Publication date: August 22, 2019
    Applicant: Koki Holdings Co., Ltd.
    Inventors: Tomomasa NISHIKAWA, Masayuki OGURA, Masaru HIRANO, Takuhiro MURAKAMI, Nobuhiro TAKANO, Osamu KAWANOBE, Akira MATSUSHITA, Hayato YAMAGUCHI
  • Publication number: 20190259985
    Abstract: In an upper cell unit (2146) and a lower cell unit (2147) comprising five battery cells, positive electrode terminals (2162, 2172) are set apart and aligned vertically, and negative electrode terminals (2167, 2177) are set apart and aligned vertically. When an electrical device body is rated at 36V, device-side terminals are in contact only at the upper terminals (2162, 2167), and short circuiting of the lower terminals (2172, 2177) is effected using a short bar 2059. When the electrical device body is rated at 18V, the upper and lower terminals (2162 and 2172, 2167 and 2177) are simultaneously made to contact the device-side terminals, and the upper cell unit (2146) and the lower cell unit (2147) assume a parallel connected state. Thus, it is possible to automatically switch the output voltage when a battery pack is mounted according to the difference in terminal shape on the electrical device body side.
    Type: Application
    Filed: October 27, 2017
    Publication date: August 22, 2019
    Applicant: Koki Holdings Co., Ltd.
    Inventors: Hiroyuki HANAWA, Tomomasa NISHIKAWA, SHOTA KANNO, Toshio Mizoguchi, Yasushi Nakano, Kazuhiko FUNABASHI, Takuya Teranishi, Naoto Wakatabe, Shinji Watanabe, Junpei Sato, Hikaru Tamura, Nobuhiro TAKANO, Osamu Kawanobe, Hayato Yamaguchi, Akira Matsushita, Masaru Hirano, Takuhiro Murakami, Masayuki Ogura, Yusuke Funabiki, Junichi Toukairin, Shota Takeuchi
  • Publication number: 20190249163
    Abstract: Methods of delivering therapeutic agents by administering compositions including a bacterial collagen-binding polypeptide segment linked to the therapeutic agent to subjects in need of treatment with the therapeutic agent are provided. In these methods, the therapeutic agent is not a PTH/PTHrP receptor agonist or antagonist, basic fibroblast growth factor (bFGF) or epidermal growth factor (EGF). The bacterial collagen-binding polypeptide segment delivers the agent to sites of partially untwisted or under-twisted collagen. Methods of treating collagenopathies using a composition including a collagen-binding polypeptide and a PTH/PTHrP receptor agonist are also provided. In addition, methods of treating hyperparathyroidism, and hair loss using compositions comprising a collagen binding polypeptide and a PTH/PTHrP receptor agonist are provided. Finally, methods of reducing hair regrowth by administering a composition including a collagen binding polypeptide and a PTH/PTHrP receptor antagonist are provided.
    Type: Application
    Filed: February 22, 2019
    Publication date: August 15, 2019
    Applicants: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSA S, The Kitasato Institute, MONTEFIORE MEDICAL CENTER, NATIONAL UNIVERSITY CORPORATION KAGAWA UNIVERISTY
    Inventors: Tulasi Ponnapakkam, Sagaya Theresa Leena Philominathan, Joshua Sakon, Ranjitha Katikaneni, Takaki Koide, Osamu Matsushita, Robert C. Gensure, Nozomu Nishi
  • Patent number: 10363888
    Abstract: A wire harness to be installed in a vehicle includes an electric wire and a protective tube that protects the electric wire. The electric wire is provided at the lower part of a vehicle body of the vehicle and the protective tube covers the electric wire and includes ferromagnetic materials.
    Type: Grant
    Filed: July 27, 2016
    Date of Patent: July 30, 2019
    Assignee: YAZAKI CORPORATION
    Inventors: Osamu Kimura, Yoshinori Matsushita, Yasuhiro Okamoto
  • Patent number: 10358471
    Abstract: Fusion proteins containing active agonist or antagonist fragments of parathyroid hormone (PTH) and parathyroid hormone related peptide (PTHrP) coupled to a collagen-binding domain are presented. The fusion proteins can be used to promote bone growth, to promote hair growth, to prevent cancer metastasis to bone, to promote immune reconstitution with a bone marrow stem cell transplant, to promote mobilization of bone marrow stem cells for collection for autologous stem cell transplant, and to treat renal osteodystrophy. Pharmaceutical agents comprising a collagen-binding polypeptide segment linked to a non-peptidyl PTH/PTHrP receptor agonist or antagonist are also presented.
    Type: Grant
    Filed: January 16, 2019
    Date of Patent: July 23, 2019
    Assignees: The Board of Trustees of the University of Arkansas, Ochsner Clinic Foundation, National University Corporation Kagawa university
    Inventors: Robert C. Gensure, Joshua Sakon, Osamu Matsushita, Tulasi Ponnapakkam
  • Publication number: 20190135890
    Abstract: Fusion proteins containing active agonist or antagonist fragments of parathyroid hormone (PTH) and parathyroid hormone related peptide (PTHrP) coupled to a collagen-binding domain are presented. The fusion proteins can be used to promote bone growth, to promote hair growth, to prevent cancer metastasis to bone, to promote immune reconstitution with a bone marrow stem cell transplant, to promote mobilization of bone marrow stem cells for collection for autologous stem cell transplant, and to treat renal osteodystrophy. Pharmaceutical agents comprising a collagen-binding polypeptide segment linked to a non-peptidyl PTH/PTHrP receptor agonist or antagonist are also presented.
    Type: Application
    Filed: January 16, 2019
    Publication date: May 9, 2019
    Applicants: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS, OCHSNER CLINIC FOUNDATION, NATIONAL UNIVERSITY CORPORATION KAGAWA UNIVERSITY
    Inventors: Robert C. Gensure, Joshua Sakon, Osamu Matsushita, Tulasi Ponnapakkam
  • Patent number: 10213488
    Abstract: Methods of delivering therapeutic agents by administering compositions including a bacterial collagen-binding polypeptide segment linked to the therapeutic agent to subjects in need of treatment with the therapeutic agent are provided. Methods of treating hyperparathyroidism, and hair loss using compositions comprising a collagen binding polypeptide and a PTH/PTHrP receptor agonist are provided. In addition, methods of reducing hair regrowth by administering a composition including a collagen binding polypeptide and a PTH/PTHrP receptor antagonist are provided.
    Type: Grant
    Filed: December 21, 2016
    Date of Patent: February 26, 2019
    Assignees: The Board of Trustees of the University of Arkansas, The Kitasato Institute, Montefiore Medical Center
    Inventors: Tulasi Ponnapakkam, Sagaya Theresa Leena Philominathan, Joshua Sakon, Ranjitha Katikaneni, Takaki Koide, Osamu Matsushita, Robert C. Gensure
  • Patent number: 10202434
    Abstract: Fusion proteins containing active agonist or antagonist fragments of parathyroid hormone (PTH) and parathyroid hormone related peptide (PTHrP) coupled to a collagen-binding domain are presented. The fusion proteins can be used to promote bone growth, to promote hair growth, to prevent cancer metastasis to bone, to promote immune reconstitution with a bone marrow stem cell transplant, to promote mobilization of bone marrow stem cells for collection for autologous stem cell transplant, and to treat renal osteodystrophy. Pharmaceutical agents comprising a collagen-binding polypeptide segment linked to a non-peptidyl PTH/PTHrP receptor agonist or antagonist are also presented.
    Type: Grant
    Filed: December 22, 2016
    Date of Patent: February 12, 2019
    Assignees: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS, OCHSNER CLINIC FOUNDATION, NATIONAL UNIVERSITY CORPORATION KAGAWA UNIVERSITY
    Inventors: Robert C. Gensure, Joshua Sakon, Osamu Matsushita, Tulasi Ponnapakkam
  • Publication number: 20180140742
    Abstract: 1) A graft material for nerve regeneration characterizing by comprising collagen-based materials containing collagen having an orientation. 2) A method for producing a graft material for nerve regeneration comprising a step of immersing the collagen-based materials containing collagen having an orientation in a solution containing a collagen-binding site-containing growth factor comprising a receptor agonist peptide and a collagen-binding peptide and binding the collagen-binding site-containing growth factor to the collagen. 3) A kit for producing a graft material for nerve regeneration characterized by comprising collagen-based materials containing collagen having an orientation, and a collagen-binding site-containing growth factor comprising a receptor agonist peptide and a collagen-binding peptide.
    Type: Application
    Filed: October 16, 2015
    Publication date: May 24, 2018
    Inventors: Kentaro UCHIDA, Gen INOUE, Hisako FUJIMAKI, Masashi TAKASO, Taro SAKU, Yoshihiro ISOBE, Osamu MATSUSHITA, Takehiko MIMA, Nozomu NISHI, Shunji HATTORI, Keisuke TANAKA, Takayuki OGURA
  • Patent number: 9777087
    Abstract: A polymer including a unit having a phthalocyanine structure, the polymer having a high capability of dispersing pigments. A pigment composition, a pigment dispersion, and a toner all having a high tinting strength.
    Type: Grant
    Filed: February 25, 2016
    Date of Patent: October 3, 2017
    Assignee: Canon Kabushiki Kaisha
    Inventors: Yasuaki Murai, Osamu Matsushita, Takayuki Toyoda, Waka Hasegawa, Ayano Mashida, Kosuke Mukumoto, Masashi Hirose
  • Publication number: 20170204390
    Abstract: Methods of delivering therapeutic agents by administering compositions including a bacterial collagen-binding polypeptide segment linked to the therapeutic agent to subjects in need of treatment with the therapeutic agent are provided. In these methods, the therapeutic agent is not a PTH/PTHrP receptor agonist or antagonist, basic fibroblast growth factor (bFGF) or epidermal growth factor (EGF). The bacterial collagen-binding polypeptide segment delivers the agent to sites of partially untwisted or under-twisted collagen. Methods of treating collagenopathies using a composition including a collagen-binding polypeptide and a PTH/PTHrP receptor agonist are also provided. In addition, methods of treating hyperparathyroidism, and hair loss using compositions comprising a collagen binding polypeptide and a PTH/PTHrP receptor agonist are provided. Finally, methods of reducing hair regrowth by administering a composition including a collagen binding polypeptide and a PTH/PTHrP receptor antagonist are provided.
    Type: Application
    Filed: January 17, 2017
    Publication date: July 20, 2017
    Applicants: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS, The Kitasato Institute, MONTEFIORE MEDICAL CENTER, NATIONAL UNIVERSITY CORPORATION KAGAWA UNIVERISTY
    Inventors: Tulasi Ponnapakkam, Sagaya Theresa Leena Philominathan, Joshua Sakon, Ranjitha Katikaneni, Takaki Koide, Osamu Matsushita, Robert C. Gensure, Nozomu Nishi
  • Publication number: 20170106093
    Abstract: Methods of delivering therapeutic agents by administering compositions including a bacterial collagen-binding polypeptide segment linked to the therapeutic agent to subjects in need of treatment with the therapeutic agent are provided. Methods of treating hyperparathyroidism, and hair loss using compositions comprising a collagen binding polypeptide and a PTH/PTHrP receptor agonist are provided. In addition, methods of reducing hair regrowth by administering a composition including a collagen binding polypeptide and a PTH/PTHrP receptor antagonist are provided.
    Type: Application
    Filed: December 21, 2016
    Publication date: April 20, 2017
    Applicants: The Board of Trustees of the University of Arkansas, The Kitasato Institute, Montefiore Medical Center
    Inventors: Tulasi Ponnapakkam, Sagaya Theresa Leena Philominathan, Joshua Sakon, Ranjitha Katikaneni, Takaki Koide, Osamu Matsushita, Robert C. Gensure
  • Publication number: 20170101457
    Abstract: Fusion proteins containing active agonist or antagonist fragments of parathyroid hormone (PTH) and parathyroid hormone related peptide (PTHrP) coupled to a collagen-binding domain are presented. The fusion proteins can be used to promote bone growth, to promote hair growth, to prevent cancer metastasis to bone, to promote immune reconstitution with a bone marrow stem cell transplant, to promote mobilization of bone marrow stem cells for collection for autologous stem cell transplant, and to treat renal osteodystrophy. Pharmaceutical agents comprising a collagen-binding polypeptide segment linked to a non-peptidyl PTH/PTHrP receptor agonist or antagonist are also presented.
    Type: Application
    Filed: December 22, 2016
    Publication date: April 13, 2017
    Applicants: OCHSNER CLINIC FOUNDATION, NATIONAL UNIVERSITY CORPORATION KAGAWA UNIVERSITY, THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
    Inventors: Robert C. Gensure, Joshua Sakon, Osamu Matsushita, Tulasi Ponnapakkam
  • Patent number: 9579273
    Abstract: Methods of delivering therapeutic agents by administering compositions including a bacterial collagen-binding polypeptide segment linked to the therapeutic agent to subjects in need of treatment with the therapeutic agent are provided. In these methods, the therapeutic agent is not a PTH/PTHrP receptor agonist or antagonist, basic fibroblast growth factor (bFGF) or epidermal growth factor (EGF). The bacterial collagen-binding polypeptide segment delivers the agent to sites of partially untwisted or under-twisted collagen. Methods of treating collagenopathies using a composition including a collagen-binding polypeptide and a PTH/PTHrP receptor agonist are also provided. In addition, methods of treating hyperparathyroidism, and hair loss using compositions comprising a collagen binding polypeptide and a PTH/PTHrP receptor agonist are provided. Finally, methods of reducing hair regrowth by administering a composition including a collagen binding polypeptide and a PTH/PTHrP receptor antagonist are provided.
    Type: Grant
    Filed: December 14, 2012
    Date of Patent: February 28, 2017
    Assignees: The Kitasato Institute, National University Corporation Kagawa University
    Inventors: Tulasi Ponnapakkam, Sagaya Theresa Leena Philominathan, Joshua Sakon, Ranjitha Katikaneni, Takaki Koide, Osamu Matsushita, Robert C. Gensure, Nozomu Nishi
  • Patent number: 9526765
    Abstract: Methods of delivering therapeutic agents by administering compositions including a bacterial collagen-binding polypeptide segment linked to the therapeutic agent to subjects in need of treatment with the therapeutic agent are provided. Methods of treating hyperparathyroidism, and hair loss using compositions comprising a collagen binding polypeptide and a PTH/PTHrP receptor agonist are provided. In addition, methods of reducing hair regrowth by administering a composition including a collagen binding polypeptide and a PTH/PTHrP receptor antagonist are provided.
    Type: Grant
    Filed: February 11, 2013
    Date of Patent: December 27, 2016
    Assignees: The Kitasato Institute
    Inventors: Tulasi Ponnapakkam, Sagaya Theresa Leena Philominathan, Joshua Sakon, Ranjitha Katikaneni, Takaki Koide, Osamu Matsushita, Robert C. Gensure
  • Patent number: 9528099
    Abstract: Fusion proteins containing active agonist or antagonist fragments of parathyroid hormone (PTH) and parathyroid hormone related peptide (PTHrP) coupled to a collagen-binding domain are presented. The fusion proteins can be used to promote bone growth, to promote hair growth, to prevent cancer metastasis to bone, to promote immune reconstitution with a bone marrow stem cell transplant, to promote mobilization of bone marrow stem cells for collection for autologous stem cell transplant, and to treat renal osteodystrophy. Pharmaceutical agents comprising a collagen-binding polypeptide segment linked to a non-peptidyl PTH/PTHrP receptor agonist or antagonist are also presented.
    Type: Grant
    Filed: June 18, 2015
    Date of Patent: December 27, 2016
    Assignees: National University Corporation Kagawa University
    Inventors: Robert C. Gensure, Joshua Sakon, Osamu Matsushita, Tulasi Ponnapakkam